GAMMA Investing’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,091
Closed -$12.2K 3914
2025
Q1
$12.2K Buy
1,091
+76
+7% +$840 ﹤0.01% 2654
2024
Q4
$10.5K Buy
1,015
+544
+115% +$5.26K ﹤0.01% 2587
2024
Q3
$4.47K Buy
471
+127
+37% +$1.1K ﹤0.01% 2788
2024
Q2
$2.93K Buy
344
+278
+421% +$2.54K ﹤0.01% 2758
2024
Q1
$611 Buy
+66
New +$581 ﹤0.01% 3065

Other funds holding ENFN

GAMMA Investing's ENFN Position: Q2 2025 in Review

GAMMA Investing sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,091 shares — an estimated $12.2K sold.

GAMMA Investing first reported a position in ENFN in Q1 2024 and held it in 5 quarters. The position peaked at $12.2K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • GAMMA Investing reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • GAMMA Investing sold 1,091 Enfusion, Inc. shares in Q2 2025, an estimated $12.2K.
  • GAMMA Investing first reported a position in Enfusion, Inc. in Q1 2024 and held it in 5 quarters.
  • GAMMA Investing's Enfusion, Inc. position peaked at $12.2K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on GAMMA Investing's 13F filing for Q2 2025, filed 14 Jul 2025.